Cervical Cancer Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: C7A5316EACE9EN
Market Monitor Global

Abstracts

Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, and abnormal vaginal discharge.

This report contains market size and forecasts of Cervical Cancer Drugs in Global, including the following market information:

Global Cervical Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cervical Cancer Drugs market was valued at 13550 million in 2021 and is projected to reach US$ 15750 million by 2028, at a CAGR of 2.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pre-malignant Lesions Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cervical Cancer Drugs include Roche, Hetero, GlaxoSmithKline, Eli Lilly, Alnylam Pharmaceuticals, Pfizer, Allergan, Biocon and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cervical Cancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cervical Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cervical Cancer Drugs Market Segment Percentages, by Type, 2021 (%)

• Pre-malignant Lesions
• Early Invasive Stage
• Advanced Invasive Stage

Global Cervical Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cervical Cancer Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinics
• Others

Global Cervical Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cervical Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cervical Cancer Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cervical Cancer Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Hetero
• GlaxoSmithKline
• Eli Lilly
• Alnylam Pharmaceuticals
• Pfizer
• Allergan
• Biocon
• Bristol-Myers Squibb
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cervical Cancer Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cervical Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CERVICAL CANCER DRUGS OVERALL MARKET SIZE

2.1 Global Cervical Cancer Drugs Market Size: 2021 VS 2028
2.2 Global Cervical Cancer Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cervical Cancer Drugs Players in Global Market
3.2 Top Global Cervical Cancer Drugs Companies Ranked by Revenue
3.3 Global Cervical Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cervical Cancer Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cervical Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cervical Cancer Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Cervical Cancer Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cervical Cancer Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cervical Cancer Drugs Market Size Markets, 2021 & 2028
  4.1.2 Pre-malignant Lesions
  4.1.3 Early Invasive Stage
  4.1.4 Advanced Invasive Stage
4.2 By Type - Global Cervical Cancer Drugs Revenue & Forecasts
  4.2.1 By Type - Global Cervical Cancer Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Cervical Cancer Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cervical Cancer Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Cervical Cancer Drugs Revenue & Forecasts
  5.2.1 By Application - Global Cervical Cancer Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Cervical Cancer Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cervical Cancer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Cervical Cancer Drugs Revenue & Forecasts
  6.2.1 By Region - Global Cervical Cancer Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Cervical Cancer Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cervical Cancer Drugs Revenue, 2017-2028
  6.3.2 US Cervical Cancer Drugs Market Size, 2017-2028
  6.3.3 Canada Cervical Cancer Drugs Market Size, 2017-2028
  6.3.4 Mexico Cervical Cancer Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cervical Cancer Drugs Revenue, 2017-2028
  6.4.2 Germany Cervical Cancer Drugs Market Size, 2017-2028
  6.4.3 France Cervical Cancer Drugs Market Size, 2017-2028
  6.4.4 U.K. Cervical Cancer Drugs Market Size, 2017-2028
  6.4.5 Italy Cervical Cancer Drugs Market Size, 2017-2028
  6.4.6 Russia Cervical Cancer Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Cervical Cancer Drugs Market Size, 2017-2028
  6.4.8 Benelux Cervical Cancer Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cervical Cancer Drugs Revenue, 2017-2028
  6.5.2 China Cervical Cancer Drugs Market Size, 2017-2028
  6.5.3 Japan Cervical Cancer Drugs Market Size, 2017-2028
  6.5.4 South Korea Cervical Cancer Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Cervical Cancer Drugs Market Size, 2017-2028
  6.5.6 India Cervical Cancer Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cervical Cancer Drugs Revenue, 2017-2028
  6.6.2 Brazil Cervical Cancer Drugs Market Size, 2017-2028
  6.6.3 Argentina Cervical Cancer Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cervical Cancer Drugs Revenue, 2017-2028
  6.7.2 Turkey Cervical Cancer Drugs Market Size, 2017-2028
  6.7.3 Israel Cervical Cancer Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Cervical Cancer Drugs Market Size, 2017-2028
  6.7.5 UAE Cervical Cancer Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Cervical Cancer Drugs Major Product Offerings
  7.1.4 Roche Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Hetero
  7.2.1 Hetero Corporate Summary
  7.2.2 Hetero Business Overview
  7.2.3 Hetero Cervical Cancer Drugs Major Product Offerings
  7.2.4 Hetero Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.2.5 Hetero Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Cervical Cancer Drugs Major Product Offerings
  7.3.4 GlaxoSmithKline Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Cervical Cancer Drugs Major Product Offerings
  7.4.4 Eli Lilly Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Alnylam Pharmaceuticals
  7.5.1 Alnylam Pharmaceuticals Corporate Summary
  7.5.2 Alnylam Pharmaceuticals Business Overview
  7.5.3 Alnylam Pharmaceuticals Cervical Cancer Drugs Major Product Offerings
  7.5.4 Alnylam Pharmaceuticals Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.5.5 Alnylam Pharmaceuticals Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Cervical Cancer Drugs Major Product Offerings
  7.6.4 Pfizer Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Allergan
  7.7.1 Allergan Corporate Summary
  7.7.2 Allergan Business Overview
  7.7.3 Allergan Cervical Cancer Drugs Major Product Offerings
  7.7.4 Allergan Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.7.5 Allergan Key News
7.8 Biocon
  7.8.1 Biocon Corporate Summary
  7.8.2 Biocon Business Overview
  7.8.3 Biocon Cervical Cancer Drugs Major Product Offerings
  7.8.4 Biocon Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.8.5 Biocon Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Cervical Cancer Drugs Major Product Offerings
  7.9.4 Bristol-Myers Squibb Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Cervical Cancer Drugs Major Product Offerings
  7.10.4 Novartis Cervical Cancer Drugs Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cervical Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Cervical Cancer Drugs Market Drivers in Global Market
Table 3. Cervical Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Cervical Cancer Drugs in Global Market
Table 5. Top Cervical Cancer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cervical Cancer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cervical Cancer Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cervical Cancer Drugs Product Type
Table 9. List of Global Tier 1 Cervical Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cervical Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cervical Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cervical Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cervical Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cervical Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cervical Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cervical Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cervical Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cervical Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cervical Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cervical Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cervical Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cervical Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cervical Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cervical Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Cervical Cancer Drugs Product Offerings
Table 32. Roche Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Hetero Corporate Summary
Table 34. Hetero Cervical Cancer Drugs Product Offerings
Table 35. Hetero Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Cervical Cancer Drugs Product Offerings
Table 38. GlaxoSmithKline Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Cervical Cancer Drugs Product Offerings
Table 41. Eli Lilly Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Cervical Cancer Drugs Product Offerings
Table 44. Alnylam Pharmaceuticals Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Cervical Cancer Drugs Product Offerings
Table 47. Pfizer Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Allergan Corporate Summary
Table 49. Allergan Cervical Cancer Drugs Product Offerings
Table 50. Allergan Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Biocon Corporate Summary
Table 52. Biocon Cervical Cancer Drugs Product Offerings
Table 53. Biocon Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Cervical Cancer Drugs Product Offerings
Table 56. Bristol-Myers Squibb Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Cervical Cancer Drugs Product Offerings
Table 59. Novartis Cervical Cancer Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cervical Cancer Drugs Segment by Type in 2021
Figure 2. Cervical Cancer Drugs Segment by Application in 2021
Figure 3. Global Cervical Cancer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cervical Cancer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cervical Cancer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cervical Cancer Drugs Revenue in 2021
Figure 8. By Type - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 12. US Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 24. China Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cervical Cancer Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cervical Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hetero Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alnylam Pharmaceuticals Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Allergan Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biocon Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Cervical Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)